Contract Development And Manufacturing Organizations (CDMO)

Experts Statements: Gabriel Haering, Cerbios Pharma

The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.

The Pharma CDMO Challenge

Arcinova Appoints Roger Kilburn as CEO

Ardena Launches Life Science Ingredients Arm

Olon Buys Indian API Plant

With this acquisition, Olon said it has successfully finalized its three-year development plan and will now move to its next target, which is to play an important role in manufacturing biologics APIs.

A Holistic System Approach

Unique Opportunity for Innovation and Improvement

A Visible Reference of Production-scale Micro Reaction Technology

A Technology on the Upswing

Benefits across Different Industries and Applications

Unsurpassed Heat and Mass Transfer Properties

Further Development Will Increase Confidence

A Boost to Efficiency, Adaptability and Responsiveness

Increased Process Performance and Safety

A Technology Whose Use is Indispensable

Flow Chemistry: Key Technology for Sustainable Processes

The Need for Innovation in Pharmaceutical Manufacturing

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

Cerbios Expands HPAI Manufacturing Capacity

Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its building dedicated for high potency active ingredients (HPAIs).

DCAT Week 2019

MENA Pharmaceutical Market

Opportunities for Western CDMOs in China

M&A in Pharma and CRO/CMO Industry

Opposites Attract

If You Want to Go Far, Go Together

Supply Security of Non-cGMP Materials

A Wide Spectrum of Contract Services

Pharma: Adapting to an Ever-Changing Environment

Winning Strategies in the Pharmaceutical CDMO Industry

East or West? East and West!

Cambrex to Acquire Halo Pharma

CatSci Appoints Paul Bradley as Head of Business Development

Celonic: Soenke Brunswieck appointed as Vice President Cell & Gene Therapy

Addressing Challenges in Sterile Manufacturing

Lonza Adds More Building Blocks for the Healthcare Continuum